Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Affymax Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Trading Report for (AFFY). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for AFFY. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

02 Nov 2016 Stock Traders Daily 6 $20.00

Affymax Inc

22 Oct 2016 S&P Capital IQ Quantitative Report 8 $92.00

"The Economy Matters" Report for AFFY: the economy's impact on AFFY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

18 Oct 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

Affymax, Inc. (AFFY) - Financial Analysis Review

Affymax, Inc. (AFFY) - Financial Analysis Review Summary Affymax, Inc. (Affymax) is a biopharmaceutical company that develops...

14 Oct 2016 GlobalData 33 $300.00

Affymax, Inc. (AFFY) - Financial Analysis Review

Affymax, Inc. (AFFY) - Financial Analysis Review Summary Affymax, Inc. (Affymax) is a biopharmaceutical company that develops...

12 Sep 2016 GlobalData 33 $300.00

AFFYMAX INC (AFFY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

03 Sep 2016 Pechala's Reports 2 $25.00

Affymax, Inc. (AFFY) - Financial Analysis Review

Affymax, Inc. (AFFY) - Financial Analysis Review Summary Affymax, Inc. (Affymax) is a biopharmaceutical company that develops...

17 Jun 2016 GlobalData 33 $300.00

Affymax, Inc.

Affymax, Inc. Summary Affymax, Inc. (Affymax) is a biopharmaceutical company that develops drugs. The company discovers...

22 Jan 2016 GlobalData 22 $300.00

Wright Investors Service Comprehensive Report for Affymax, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

11 Dec 2015 Wright Reports 56 $75.00